Parker Institute for Cancer Immunotherapy
Parker Institute for Cancer Immunotherapy
Want to make a donation using Daffy?
Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.
Do you work for Parker Institute for Cancer Immunotherapy? Learn more here.
By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.
About this organization
Mission
The Parker Institute for Cancer Immunotherapy (PICI) was created to encourage advances in cancer immunotherapy research and to help reduce obstacles to collaboration, discovery and translation of these advances for patients. The institute achieves this goal by funding a consortium of preeminent academic and medical research institutions which work collaboratively on research in the field of cancer immunotherapy. In addition, PICI furthers its charitable purposes by employing its own personnel to directly conduct research and clinical trials.
About
The Parker Institute for Cancer Immunotherapy encourages advances in cancer immunotherapy research to help reduce obstacles to collaboration, discovery and translation of these advances for patients. The institute funds a consortium of preeminent academic and medical research institutions which work collaboratively on research and clinical trials in the field of cancer immunology. In addition, the institute conducts its own research and clinical trials and provides consortium members with shared research resources, such as scientific equipment and consumables, and a specimen biobank.
Interesting data from their 2020 990 filing
The filing reveals the mission of the non-profit as “To enable real collaboration, accelerating the most ambitious research to deliver new immunotherapies engineered to save lives.”.
When detailing its functions, they were listed as: “The parker institute for cancer immunotherapy (pici) was created to encourage advances in cancer immunotherapy research and to help reduce obstacles to collaboration, discovery and translation of these advances for patients. the institute achieves this goal by funding a consortium of preeminent academic and medical research institutions which work collaboratively on research in the field of cancer immunotherapy. in addition, pici furthers its charitable purposes by employing its own personnel to directly conduct research and clinical trials.”.
- According to the law, the state where the non-profit operates has been reported as CA.
- The filing specifies that the non-profit's address in 2020 was 1 LETTERMAN DRIVE D3500, SAN FRANCISCO, CA, 94129.
- As of 2020, the non-profit's form shows they have a total of 80 employees.
- Is not a private foundation.
- Expenses are greater than $1,000,000.
- Revenue is greater than $1,000,000.
- Revenue less expenses is $47,236,985.
- The organization has 2 independent voting members.
- The organization was formed in 2015.
- The organization pays $16,056,809 in salary, compensation, and benefits to its employees.
- The organization pays $0 in fundraising expenses.